96826-25-4

Basic information

• Product Name: 2-(2-fluoro-4-methoxyphenyl)propan-2-ol
• Synonyms: 2-(2-fluoro-4-methoxyphenyl)propan-2-ol;Benzenemethanol, 2-fluoro-4-methoxy-α,α-dimethyl-
• CAS NO: 96826-25-4
• Molecular Formula: C₁₀H₁₃FO₂
• Molecular Weight: 184.2074232
• Mol File: 96826-25-4.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 262.8±30.0 °C(Predicted)
• Appearance: /
• Density: 1.114±0.06 g/cm3(Predicted)
• PKA: 14.09±0.29(Predicted)
• CAS DataBase Reference: 2-(2-fluoro-4-methoxyphenyl)propan-2-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-fluoro-4-methoxyphenyl)propan-2-ol(96826-25-4)
• EPA Substance Registry System: 2-(2-fluoro-4-methoxyphenyl)propan-2-ol(96826-25-4)

Safety Data

• Hazardous Substances Data: 96826-25-4(Hazardous Substances Data)

Usage

Physical State

White crystalline solid

Solubility

Soluble in water

Usage

Pharmaceutical intermediate

Applications

+ Synthesis of pharmaceutical and medicinal compounds
+ Antihistamines
+ Anti-inflammatory drugs
+ Potential anti-cancer properties (inhibits growth of certain cancer cells)

Additional Properties

+ Antioxidant activity
+ Promising compound for further research in medicinal chemistry and pharmaceutical development

Upstream product

• 74457-86-6 1-(2-fluoro-4-methoxyphenyl)-1-ethanone 
• 74-88-4 methyl iodide 
• 75-16-1 methylmagnesium bromide 
• 676-58-4 methylmagnesium chloride 

Downstream Products

• 875446-55-2 2-fluoro-4-methoxy-1-(prop-1-en-2-yl)benzene 
• 1262414-96-9 2-(2-fluoro-4-methoxyphenyl)isopropane 
• 944317-92-4 1-bromo-4-fluoro-2-methoxy-5-(propan-2-yl)-benzene 
• 1312671-75-2 5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4'-fluoro-2'-methoxy-5'-(propan-2-yl)-4-(trifluoromethyl)biphenyl-2-yl]methyl}-4,4-dimethyl-1,3-oxazolidin-2-one 
• 875548-98-4 2'-(bromomethyl)-4-fluoro-2-methoxy-5-(propan-2-yl)-4'-(trifluoromethyl)biphenyl 
• 875446-57-4 1-fluoro-4-iodo-2-isopropenyl-5-methoxybenzene 
• 1312671-76-3 (+)-(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4'-fluoro-2'-methoxy-5'-(propan-2-yl)-4-(trifluoromethyl)biphenyl-2-yl]methyl}-4,5-dimethyl-1,3-oxazolidin-2-one 
• 875549-49-8 (+)-(5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4'-fluoro-2'-methoxy-5'-(propan-2-yl)-4-(trifluoromethyl)biphenyl-2-yl]methyl}-4,4-dimethyl-1,3-oxazolidin-2-one 
• 1312671-81-0 (-)-(5S)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4'-fluoro-2'-methoxy-5'-(propan-2-yl)-4-(trifluoromethyl)biphenyl-2-yl]methyl}-4,4-dimethyl-1,3-oxazolidin-2-one 
• 875548-97-3 (4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)methanol 
• 875446-29-0 [4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]boronic acid 
• 96826-32-3 2,3-bis(2-fluoro-4-methoxyphenyl)-2,3-dimethylbutane 
• 96826-17-4 2,3-Bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane 
• 1383814-83-2 4-fluoro-2-methoxy-5-(2-propenyl)phenylboronic acid 

Relevant articles and documents

Native Amine-Directed ortho -C-H Halogenation and Acetoxylation /Condensation of Benzylamines

Free or unfunctionalized benzylamines are well known to participate in C-H activation in the presence of palladium salts. Despite the ease with which these complexes can be activated, subsequent functionalization of the dimeric cyclometalates can be chall

PROCESS FOR A CETP INHIBITOR

An efficient process is disclosed for producing the compound of formula I, which is the CETP inhibitor anacetrapib, which raises HDL-cholesterol and reduces LDL-cholesterol in human patients and may be effective for treating or reducing the risk of developing atherosclerosis:.

SYNTHESIS OF INTERMEDIATES FOR PREPARING ANACETRAPIB AND DERIVATIVES THEREOF

The present invention relates to the field of organic chemistry, more specifically to the synthesis of intermediate compounds which can be used in the synthesis of pharmaceutically active agents such as anacetrapib or derivatives thereof.